Imaging the paediatric lung: What does nanotechnology have to offer?

Paediatric Respiratory Reviews

Volumn 13, Issue 2, 2012, Pages 84-88

  Ordidge, K L ^a   Duffy, B A ^a   Wells, J A ^a   Kalber, T L ^a   Janes, S M ^a   Lythgoe, M F ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Diagnostic imaging; Lung; Nanoparticles

Indexed keywords

CARBON NANOTUBE; CONTRAST MEDIUM; DOXORUBICIN; GADOLINIUM; NANOPARTICLE; RHENIUM 188; SINGLE WALLED NANOTUBE; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

CELL TRACKING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CYSTIC FIBROSIS; EARLY DIAGNOSIS; HUMAN; IMAGING; LUNG; LUNG CANCER; LUNG METASTASIS; MOLECULAR IMAGING; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CHILD; HUMANS; LUNG; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; NANOPARTICLES; NANOTECHNOLOGY; RADIONUCLIDE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84859270588     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2011.07.001     Document Type: Review

References (43)

1. Nune S.K., Gunda P., Thallapally P.K., Lin Y.Y., Forrest M.L., Berkland C.J. Nanoparticles for biomedical imaging. Expert Opin Drug Deliv 2009, 6:1175-1194.
2. Bulte J.W.M. In vivo MRI cell tracking: Clinical studies. AJR 2009, 193:314-325.
3. Shubayev V.I., Pisanic T.R., Jin S. Magnetic nanoparticles for theragnostics. Advanced Drug Delivery Reviews 2009, 61:467-477.
4. Ayyagari A.L., Zhang X., Ghaghada K.B., Annapragada A., Hu X., Bellamkonda R.V. Long-circulating liposomal contrast agents for magnetic resonance imaging. Magn Res Med 2006, 55:1023-1029.
5. Hong H., Gao T., Cai W. Molecular imaging with single-walled carbon nanotubes. Nano Today 2009, 4:252-261.
6. Torchilin V. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Deliver Rev 2002, 54:235-252.
7. Smith A.M., Duan H., Mohs A.M., Nie S. Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliver Rev 2008, 60:1226-1240.
8. Nassimi M., Schleh C., Lauenstein H.D., et al. A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. Eur J Pharm Biopharm 2010, 75:107-116.
9. Bur M., Henning A., Hein S., Schneider M., Lehr C.M. Inhalative nanomedicine- opportunities and challenges. Inhal Toxicol 2009, 21:137-143.
10. Zhang J., Wu L., Chan H.-K., Watanabe W. Formation, characterization and fate of inhaled drug nanoparticles. Adv Drud Del Rev 2011, 63:441-455.
11. Runge VM Wood ML. Fast imaging and other motion artifact reduction schemes: a pictorial overview. Mag Reson Imag 1988;6: 595-608.
12. Togao O., Tsuji R., Ohno Y., Dimitrov I., Takahashi M. Ultrashort echo time (UTE) MRI of the lung: assessment of tissue density in the lung parenchyma. Magn Reson Med 2010, 64:1491-1498.
13. Hatabu H, Chen Q, Stock KW, Gefter WB, Itoh H. Fast magnetic resonance imaging of the lung. Eur J Radiol 1999;29:114-32.
14. Takahashi M, Togao O, Obara M, van Cauteren M, Ohno Y, Doi S, Kuro-o M, Malloy C, Hsia CC, Dimitrov I. Ultra-short echo time (UTE) MR imaging of the lung: comparison between normal and emphysematous lungs in mutant mice 2010;32:326-33.
15. Zapke M, Topf HG, Zenker M, et al. Magnetic resonance lung function- a breakthrough for lung imaging and functional assessment? A phantom study and clinical trial. Respir Res 2006;6:106.
16. Santyr GE, Lam WW, Parra-Robles JM, Taves TM, Ouriado AV., Hyperpolarised noble gas magnetic resonance imaging of the animal lung: approaches and applications. J Appl Phys 2009;105:102004-1-13.
17. Salerno M, Altes TA, Mugler JP III, Nakatsu M, Hatabu H, de Lange EE. Hyperpolarised noble gas MR imaging of the lung: Potential clinical applications. Eur J Radiol 2001;40:33-44.
18. Ohno Y., Chen Q., Hatabu H. Oxygen-enhanced magnetic resonance ventilation imaging of lung. Eur J Radiol 2001, 37:164-171.
19. Pankhurst Q.A., Connolly J., Jones S.K., Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys 2003, 36:R167-R181.
20. Moller H.E., Chen X.J., Saam B., Hagspiel K.D., Johnson G.A., Altes T.A., de Lange E.E., Kauczor H.-U. MRI of the lungs using hyperpolarized noble gases. Magn Reson Med 2002, 47:1029-1051.
21. Branca R.T., Cleveland Z.I., Fubara B., Kumar C., Maronpot R.R., Leuschner C., et al. Molecular MRI for sensitive and specific detection of lung metastases. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:3693-3697. Available from ://WOS: 000275130900075.
22. Iyer A.K., Khaled G., Fang J., Maeda H. Exploiting the enhanced permeability and retention effect for tumour targeting. Drug Discovery Today 2006, 11:812-818.
23. Jain TK, Foy SP, Erokwu B, Dimitrijevic S, Flask CA, Labhasetwar V. Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. Biomaterials 2009;30:6748-56.
24. Farrell E, Wielopolski P, Pavljasevic P, van Tiel S, Jahr H, Verhaar J, Weinans H, Krestin G, O'Brien FJ, van Osch G, Bernsen M. Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochemical and Biophysical Research Coomunications 2008;369:1076-81.
25. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. The Iinternational Journal of Biochemistry & Cell Biology 2004;36:568-84.
26. Loebinger Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Research 2009, 69:8862-8867.
27. Loebinger M.R., Kyrtatos P.G., Turmaine M., Price A.N., Pankhurst Q., Lythgoe M.F., Janes S.M. Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer. Cancer Research 2009, 69:4134-4142.
28. Leblond AL, Naud P, Forest V, Gourden C, et al. Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury. Hum Gene Ther 2009;20:1329-43.
29. Hu Y.-L., Fu Y.-H., Tabata Y., Gao J.-Q. Mesenchymal stem cells: A promising targeted-delivery vehicle in cancer gene therapy. J Control Release 2010, 147:154-162.
30. Riegler J, Wells J, Kyratatos PG, Price AN, Pankhurst QA, Lythgoe MF. Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system. Biomaterials 2010;31:5366-71.
31. Serdons K, Verbruggen A, Bormans GM. Developing new molecular imaging probes for PET. Methods 2009;48:104-11.
32. Lee H-Y, Li Z, Chen K., Hsu A, Xu C, Xie J, Sun S, Chen X., PET/MRI dual- modality tumour imaging using arginine-glycine-aspartic (RGD)- conjugated radiolabeled iron oxide nanoparticles. J Nucl Med 2008;49:1371-79.
33. Rossin R., Muro S., Welch M.J., Muzykantov V.R., Schuster D.P. In vivo imaging of Cu-64-labeled polymer nanoparticles targeted to the lung endothelium. Journal of Nuclear Medicine 2008, 49:103-111. Available from ://000252391700023.
34. Koshkina N.V., Golunski E., Roberts L.E., Gilbert B.E., Knight V. Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice. Journal of Aerosol Medicine-Deposition Clearance and Effects in the Lung 2004, 17:7-14. Available from ://WOS: 000228611500002.
35. Yang W., Peters J.I., Williams R.O. Inhaled nanoparticles- A current review. Int J Pharm 2008, 356:239-247.
36. Videira MA, Botelho MF, Santos AC, Gouveia LF, Pedroso de Lima JJ, Almeida AJ. Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles. Journal of Drug Targeting 2002;10:607-13.
37. Hong S.Y., Tobias G., Al-Jamal K.T., Ballesteros B., Ali-Boucetta H., Lozano-Perez S., et al. Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. Nature Materials 2010, 9:485-490. Available from ://WOS: 000277926600015.
38. Lam C.-W., James J.T., McCluskey R., Arepalli S., Hunter R.L. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Cr Rev Toxicol 2006, 36:189-217.
39. Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, Alexander A, Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 2006;92:5-22.
40. Welch M.J., Hawker C.J., Wooley K.L. The advantages of nanoparticles for PET. J Nucl Med 2009, 50:1743-1746.
41. Chang Y.-J., Chang H.C., Yu C.-Y., Chang T.-J., Chen L.-C., Chen M.-H., Lee T.-W., Ting G. Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumour model. Nuc Med Bio 2010, 37:95-104.
42. Hainfeld J.F., Slatkin D.N., Focella T.M., Smilowitz H.M. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006, 79:248-253.
43. Aillon KL, El-Gendy N, McDonald J, Dennis C, Berkland C. Iodinated nanolusters as an inhaled CT contrast agent for lung visualisation. Mol Pharm 2010; 7:1274-82.